Surgical Management of Pediatric Crohn's Disease

Elsevier

Available online 28 March 2024, 151401

Seminars in Pediatric SurgeryAuthor links open overlay panel, ABSTRACT

Management of pediatric-onset Crohn's disease uniquely necessitates consideration of growth, pubertal development, psychosocial function and an increased risk for multiple future surgical interventions. Both medical and surgical management are rapidly advancing; therefore, it is increasingly important to define the role of surgery and the breadth of surgical options available for this complex patient population. Particularly, the introduction of biologics has altered the disease course; however, the ultimate need for surgical intervention has remained unchanged. This review defines and evaluates the surgical techniques available for management of the most common phenotypes of pediatric-onset Crohn's disease as well as identifies critical perioperative considerations for optimizing post-surgical outcomes.

Section snippetsINTRODUCTION

Crohn's disease (CD) is a chronic inflammatory condition which manifests as progressive intestinal damage in predisposed individuals with unknown environmental exposures.1, 2, 3 Although the exact etiopathogenesis remains elusive, there is evidence for 71 susceptibility loci on 17 chromosomes which results in intestinal immune dysfunction and abnormal interactions with typical symbiotic intestinal commensal microbiota.1,4,5 This ultimately produces the characteristic patchy intestinal luminal

Surgical Indications

In pediatric-onset CD, surgical intervention is necessitated in three principal circumstances—failure of medical therapy, growth failure, and management of disease complications. Inadequacy of medical therapy may manifest as the escalation of symptoms despite optimized maintenance therapy or the development of antibodies to biologics rendering them ineffective. Furthermore, avoidance of long-term corticosteroid dependence is essential in children due to metabolic consequences and deleterious

Small Bowel and Ileocolonic Resections

Disease activity in pediatric CD most commonly (53%) presents in a patchy distribution in both the ileum and colon while 16% have isolated ileocecal disease and only 4% have disease isolated proximal to the terminal ileum.47 In patients with limited active small bowel or ileocolonic disease, segmental resection to grossly negative margins is sufficient, rarely requiring proximal diversion. Within the adult literature, the type of anastomosis has been found to impact short and long-term outcomes

Enhanced Recovery Protocols

Enhanced recovery protocols (ERPs) are a collection of standardized interventions with demonstrated improvements in postoperative outcomes, resource utilization and patient satisfaction while expediting recovery.140,141 Widespread adoption in adult colorectal surgery has demonstrated decreased complication rates, opioid utilization, length of stay and hospital costs; however, there is a lack of utilization of ERPs in pediatric surgery with less than 20% of surveyed pediatric surgeons reporting

CONCLUSION

CD can result in significant morbidity and diminished quality of life for patients of all ages; however, pediatric-onset CD demands unique considerations regarding a patient's growth, pubertal development and psychosocial function and their increased need for surgical interventions.160 Although advances in medical therapy have significantly altered the disease course for CD, ultimate need for surgical intervention remains unchanged.9,22 Surgical advances have been complimentary in improving

DISCLOSURE

All authors have no conflicts of interest to disclose. There is no funding to declare.

ACKNOWLEDGEMENTS

Table 1 was adapted from an article published by BMC (Springer Nature) and is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

REFERENCES (160)MK Krane et al.A new antimesenteric functional end-to-end handsewn (Kono-S) anastomosis: feasibility and short-term outcomes in Crohn's disease

Journal of the American College of Surgeons

(2015)

E Romeo et al.Strictureplasty and intestinal resection: different options in complicated pediatric-onset Crohn disease

J Pediatr Surg

(May 2012)

RN Baldassano et al.Pediatric Crohn's disease: risk factors for postoperative recurrence

Am J Gastroenterol

(Jul 2001)

SF Polites et al.Long-term outcomes of ileal pouch-anal anastomosis for pediatric chronic ulcerative colitis

J Pediatr Surg

(Oct 2015)

A Karabulut et al.Crohn's disease from past to present: Research trends and global outcomes with scientometric analysis during 1980 to 2022

Medicine (Baltimore)

(Sep 1 2023)

Y Ogura et al.A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

Nature

(May 31 2001)

JP Hugot et al.Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

Nature

(May 31 2001)

A Franke et al.Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

Nat Genet

(Dec 2010)

A Corsello et al.Transition of inflammatory bowel disease patients from pediatric to adult care: an observational study on a joint-visits approach

Ital J Pediatr

(Jan 28 2021)

MD Kappelman et al.Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population

Dig Dis Sci

(Feb 2013)

CN Bernstein et al.The epidemiology of inflammatory bowel disease in Canada: a population-based study

Am J Gastroenterol

(Jul 2006)

D. von AllmenPediatric Crohn's Disease

Clin Colon Rectal Surg

(Mar 2018)

SB. SnapperVery-Early-Onset Inflammatory Bowel Disease

Gastroenterol Hepatol (N Y)

(Aug 2015)

LM Mackner et al.Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

J Pediatr Gastroenterol Nutr

(Apr 2013)

B Pigneur et al.Natural history of Crohn's disease: comparison between childhood- and adult-onset disease

Inflamm Bowel Dis

(Jun 2010)

R Heuschkel et al.Guidelines for the management of growth failure in childhood inflammatory bowel disease

Inflamm Bowel Dis

(Jun 2008)

IR Sanderson et al.Remission induced by an elemental diet in small bowel Crohn's disease

Arch Dis Child

(Feb 1987)

F Emma et al.Long-term linear growth of children with severe steroid-responsive nephrotic syndrome

Pediatr Nephrol

(Aug 2003)

AM Boot et al.Bone mineral density and nutritional status in children with chronic inflammatory bowel disease

Gut

(Feb 1998)

AM. GriffithsGrowth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently?

Dig Dis

(2009)

J Ezri et al.Impact of disease and treatments on growth and puberty of pediatric patients with inflammatory bowel disease

Digestion

(2012)

H Hildebrand et al.Longitudinal growth in children and adolescents with inflammatory bowel disease

J Pediatr Gastroenterol Nutr

(Feb 1994)

AB Lipson et al.Acceleration of linear growth following intestinal resection for Crohn disease

Eur J Pediatr

(Jul 1990)

MD Mandel et al.Have biologics changed the natural history of Crohn's disease?

Dig Dis

(2014)

P Andersson et al.Surgery for Crohn colitis over a twenty-eight-year period: fewer stomas and the replacement of total colectomy by segmental resection

Scand J Gastroenterol

(Jan 2002)

JB Mitsuya et al.The Effect of Biologics on Postoperative Complications in Children With Inflammatory Bowel Disease and Bowel Resection

J Pediatr Gastroenterol Nutr

(Mar 2019)

LA Zimmerman et al.Postoperative Complications in Children With Crohn Disease Treated With Infliximab

J Pediatr Gastroenterol Nutr

(Sep 2016)

Y Xu et al.Meta-Analysis: The Influence of Preoperative Infliximab Use on Postoperative Complications of Crohn's Disease

Inflamm Bowel Dis.

(Jan 10 2019)

U Ahmed Ali et al.Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn's disease

Dis Colon Rectum

(May 2014)

J Amil-Dias et al.Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Porto Group of ESPGHAN

J Pediatr Gastroenterol Nutr

(May 2017)

B Pasternak et al.Perioperative Management of Pediatric Crohn's Disease

J Pediatr Gastroenterol Nutr

(Feb 1 2023)

V Subramanian et al.Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery

Am J Gastroenterol

(Sep 2008)

CW Hicks et al.Perioperative corticosteroid management for patients with inflammatory bowel disease

Inflamm Bowel Dis

(Jan 2015)

N Gupta et al.Presentation and disease course in early- compared to later-onset pediatric Crohn's disease

Am J Gastroenterol

(Aug 2008)

T Yamamoto et al.Risk factors for intra-abdominal sepsis after surgery in Crohn's disease

Dis Colon Rectum

(Aug 2000)

A Alves et al.Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients

Dis Colon Rectum

(Mar 2007)

D Hu et al.Exclusive enteral nutritional therapy can relieve inflammatory bowel stricture in Crohn's disease

J Clin Gastroenterol

(Oct 2014)

N Narula et al.Enteral nutritional therapy for induction of remission in Crohn's disease

Cochrane Database Syst Rev

(Apr 1 2018)

RB Heuschkel et al.Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children

J Pediatr Gastroenterol Nutr

(Jul 2000)

P Dziechciarz et al.Meta-analysis: enteral nutrition in active Crohn's disease in children

Aliment Pharmacol Ther

(Sep 15 2007)

View full text

© 2024 Published by Elsevier Inc.

留言 (0)

沒有登入
gif